Journals / Romatizma Dergisi / 2002 / Cilt: 17 - Sayı: 1

Intra-articular injection of sodium hyaluronate in the treatment of knee osteoarthritis

Diz osteoartriti tedavisinde intraartiküler sodyum hyaluronat enjeksiyonu

Pages
31–38
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It is concluded that sodium hyaluronate offers no significant benefit over plcebo during a 5 week treatment period.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine the effects of intra-articular hyaluronan on the symptoms, of knee osteoarthritis (OA).
📊
Key Findings & Data:All of them (total 56 knees) had grade II or III degeneration radiologically according to Kellgren-Lawrence method.
💡
Conclusion & Impact:Conclusion: It is concluded that sodium hyaluronate offers no significant benefit over plcebo during a 5 week treatment period.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Enjeksiyon · eklem içi · Plasebo

Abstract

Objective: To determine the effects of intra-articular hyaluronan on the symptoms, of knee osteoarthritis (OA). Methods: Twenty-eight pallets with bilateral knee OA (ACR criteria) were included in this double-blind, randomised and placebo-controlled trial. All of them (total 56 knees) had grade II or III degeneration radiologically according to Kellgren-Lawrence method. One knee for every patient was assigned randomly by active treatment and applied 2 ml solution of sodium hyaluronate intra-articularly(15 mg/ml) and the contralateral knee was accepted as placebo and injected 2 ml physiological saline, within the same procedure, once a week for 3 consecutive weeks. Efficacy on pain, function, stiffness, motion, activity and tolerability were evaluated with detailed parameters at weeks 1,2,3 and 5. Results: No side effects developed during a 5 week period. Both groups, according to patients, were improved at 5 week compared with baseline but there was no statistically significant difference between two groups. The efficacies of hyaluronan and saline solutions were similar on the all parameters. Conclusion: It is concluded that sodium hyaluronate offers no significant benefit over plcebo during a 5 week treatment period.

Özet

Çalışmanın amacı: intra-artiküler hyaluronan injeksiyonlarının diz osteoartriti (OA) üzerindeki etkilerini araştırmak. Hastalar ve Yöntem: ACR (American Collage of Rheumatology) kriterlerine göre bilateral OA tanısı konmuş 28 hasta bu çift-kör, randomize ve plasebo kontrollü çalışmaya dahil edildi. Toplam 56 diz Kellgren-Lawrence radyolojik skorlamasına göre grade II veya III dejenerasyona sahiptir. Her hastanın bir dizi rastgele aktif olarak kabul edilip 2 ml intraartiküler sodyum hyaluronate solüsyonu (15 mg/ml) enjekte edildi. Diğer diz plasebo kabul edilerek 2 ml serum fizyolojik aynı şartlarda ve aynı seansta yapıldı. Haftada 1 enjeksiyon olmak üzere öncesi 1., 2., 3. ve 5. hafta sonu olmak üzere 5 kez yapıldı. Sonuçları 5 Haftalık izleme peryodu sırasında önemli kabul edilecek hiçbir yan etkiye rastlanmadı. Her iki grupta 5. hafta sonunda başlangıca göre anlamlı düzelmeler görüldü ancak aktif grup lehine olan istatistiksel olarak anlamlı düzelme dışında diğer parametrelerde fark görülmedi. Hyaluronan ve serum fizyolojik injeksiyonlarının diz ozteoartriti üzerine etkisi genellikle benzerdi. Sonuç: Sodyum hyaluronatın diz osteoartriti üzerine 5 haftalık takip peryodu boyunca etkisi plaseboya benzer bulunmuştur.

🔖

Cite This Article

BÜTÜN, B., KAÇAR, C., EVCİK, D. (2002). Intra-articular injection of sodium hyaluronate in the treatment of knee osteoarthritis. Romatizma Dergisi, Cilt: 17 - Sayı: 1, 31–38. https://ajindex.com/articles/306053

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Kramer JS, Yelin EH, Epstein WV. Social and economic impacts of four musculosceletal conditions. Arthritis Rheum 1983;26:901-7
  2. Gardner DL. The nature and causes of osteoarthrosis. BMJ 1983;.286: 418-24
  3. Adams ME. Diagnosing osteoarthritis and minimizing the effects. Medicine North Am 1991; 4: 3082-90
  4. Pelletier J-P. Osteoarthritis: update on diagnosis and therapy. J Rheumatol 1991; 18(Suppl 27): 1-149
  5. Balazs EA. The physical properties of synovial fluid and special role of hyaluronic acid. In Helfet A, Ed. Disorders of the knee, 2nd ed. Philadelphia, PA: JB Lippincott Company 1981: 61-74
  6. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993; 20 (Suppl 39): 3-9
  7. Balazs EA, Watson D, Duff IF, Roiseman S. Hyaluronic acid in synovial fluid. I. Moleculer parameters of hyaluronic acid in normal and arthitic human synovial fluid. Arthritis Rheum 1967; 10: 357-76
  8. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarhritis. J Rheumatol 1993; 20 (Suppl 39): 3-9
  9. Weiss C, Band P, Basic principles underlying the development of viscosupplementation for the treatment of osteoarthritis. J Clin Rheum 1999; 5: 6 (suppl):3-11
  10. Fraser JRE, Kimpton WG, Laurent TC, Cahili RNP, Vakakis N. Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J 1988;256:153-8
  11. Wen DY. Intra-articular hyaluronic acid injections for knee osteoarthritis. Am Fam Physician 2000 Aug; 62(3): 565-70, 572
  12. Watterson JR, Esdaile JM. Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarhritis of the knee. J Am Acad Orthop Surg 2000; 8(5):277-84
  13. Rosier RN, O'Keefe RJ. Hyaluronic acid therapy. Instr Course Lect 2000;49:495-502
  14. Takahashi K, Goomer RS, Harwood F, Kubo T, Hİrasawa Y, Amiel D. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1 beta (IL-1 beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarhritis. Osteoarthitis Cartilage 1999;7(2):182-90
  15. Takahashi K, Hashimato S, Kubo T, Hirasawa Y, Lotz M, Amiel D. Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarhritis. J Rheumatol 2000; 27(7):1713-20
  16. Wenz W, Breusch SJ, Graf J, Stratmann U. Ultrastructural findings after intraarticular application of hyaluronan in a canine model of arhropathy. J Orthop Res 2000; 18(4):604-12. 17